生命科学资讯

JPM recap; Mirador raises $250M; Genentech’s PBM shift; and more

Agomab and SpyGlass file for IPOs as investor enthusiasm builds after JPM

AbbVie, Genmab say Epkinly didn't prolong overall survival in lymphoma study

Drugmakers without MFN pacts are bracing to make one

Supreme Court will hear Hikma’s ‘skinny label’ fight against Amarin

Makary talks FDA's plans to combat China's biotech growth

ImmunityBio's cell therapy posts encouraging early data in rare blood cancer

#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026

European regulators recommended 38 novel drugs in 2025, 15 fewer than the FDA

Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisai

New York sues ex-Emergent CEO over insider trading during vaccine manufacturing struggle

Trump asks Congress to codify ‘most favored nation’ deals

The newest women’s health unicorn

A compounding pharmacy hits back at Eli Lilly, Novo Nordisk with antitrust lawsuit

Inside Fosun Pharma's ambition to reach outside of China

Alfasigma gains neuro treatment; BridgeBio offers $550M in notes

FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory

Ocugen touts Phase 2 data for eye disease gene therapy

J&J reports positive Phase 3 data for Tecvayli in earlier blood cancer setting

Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035